( 01548.hk) | 1.07 | 0.75 | 0% | 上市时间2015-12-30股价11.87港币涨跌幅-2.94%成交金额9,241.17万港币换手率0.35%市值259.54亿港币H股市值259.54亿港币总股本21.87亿H股本21.87亿每手股数2,000上市至今年化投资收益率23.89%港股通持仓占H股比例26.46% (71.22亿港币2026-02-23) 累计做空占H股比例4.92% (12.96亿港币2026-02-13) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 65.03 | 市净率 | 4.93 | 股息率 | 0.32% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 |
| ||||||
| 备注 (12): | 双击编辑备注 |
金斯瑞生物科技(01548) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 章方良 | Executive Director | 2022-12-17 | -- | |
| 2 | 章方良 | Non Executive Director | 2022-05-02 | 2022-12-17 | |
| 3 | 王學海 | Independent Non Executive Director | 2020-11-22 | -- | |
| 4 | 朱力 | Executive Director | 2020-11-22 | -- | |
| 5 | 章方良 | Non Executive Director | 2020-08-02 | 2020-11-22 | |
| 6 | 潘九安 | Independent Non Executive Director | 2018-11-26 | -- | |
| 7 | 王佳芬 | Non Executive Director | 2018-11-26 | -- | |
| 8 | 戴祖勉 | Independent Non Executive Director - A/F | 2015-08-24 | -- | |
| 9 | 郭宏新 | Independent Non Executive Director | 2015-08-24 | -- | |
| 10 | 孟建革 | Executive Director | Chairman | 2015-08-24 | -- |
| 11 | 潘躍新 | Non Executive Director | 2015-08-24 | -- | |
| 12 | 王魯泉 | Non Executive Director | 2015-08-24 | -- | |
| 13 | 王燁 | Executive Director | 2015-08-24 | -- | |
| 14 | 張敏 | Independent Non Executive Director | 2015-08-24 | 2018-11-26 | |
| 15 | 黄瑞瑨 | Non Executive Director | 2015-08-24 | 2018-01-05 | |
| 16 | 章方良 | Executive Director | Chairman | 2015-05-21 | 2020-08-02 |